Enanta Pharmaceuticals (ENTA) Revenue (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.82% |
| Dec 31, 2025 | 23.07% |
| Sep 30, 2025 | -17.41% |
| Jun 30, 2025 | 22.70% |
| Mar 31, 2025 | -11.99% |
| Dec 31, 2024 | 16.10% |
| Sep 30, 2024 | -18.72% |
| Jun 30, 2024 | 5.38% |
| Mar 31, 2024 | -5.27% |
| Dec 31, 2023 | -4.91% |
| Sep 30, 2023 | 0.21% |
| Jun 30, 2023 | 6.16% |
| Mar 31, 2023 | -24.55% |
| Dec 31, 2022 | 16.09% |
| Sep 30, 2022 | 4.30% |
| Jun 30, 2022 | 4.08% |
| Mar 31, 2022 | -32.31% |
| Dec 31, 2021 | 17.28% |
| Sep 30, 2021 | 9.02% |
| Jun 30, 2021 | 7.41% |
| Mar 31, 2021 | -36.58% |
| Dec 31, 2020 | 34.33% |
| Sep 30, 2020 | 26.69% |
| Jun 30, 2020 | -32.46% |
| Mar 31, 2020 | -47.46% |
| Dec 31, 2019 | 2.45% |
| Sep 30, 2019 | 15.66% |
| Jun 30, 2019 | 11.95% |
| Mar 31, 2019 | -43.29% |
| Dec 31, 2018 | 3.99% |
| Sep 30, 2018 | 17.36% |
| Jun 30, 2018 | 30.00% |
| Mar 31, 2018 | 15.59% |
| Dec 31, 2017 | -49.81% |
| Sep 30, 2017 | 910.88% |
| Jun 30, 2017 | -16.16% |
| Mar 31, 2017 | -14.00% |
| Dec 31, 2016 | -18.88% |
| Sep 30, 2016 | -8.13% |
| Jun 30, 2016 | 7.49% |
| Mar 31, 2016 | -73.16% |
| Dec 31, 2015 | 236.05% |
| Sep 30, 2015 | 24.29% |
| Jun 30, 2015 | -79.78% |
| Mar 31, 2015 | -25.98% |
| Dec 31, 2014 | 2,838.87% |
| Sep 30, 2014 | -93.73% |
| Jun 30, 2014 | 1,846.81% |
| Mar 31, 2014 | 141.88% |
| Dec 31, 2013 | -33.80% |
| Sep 30, 2013 | -18.19% |
| Jun 30, 2013 | 37.88% |
| Mar 31, 2013 | -95.71% |
| Dec 31, 2012 | 1,399.41% |
| Sep 30, 2012 | -26.91% |
| Jun 30, 2012 | -93.05% |